Viatris Company Insiders

VTRS Stock  USD 11.36  0.11  0.98%   
Viatris' insiders are aggressively selling. The analysis of insiders' sentiment of trading Viatris stock suggests that vertually all insiders are panicking at this time. Viatris employs about 38 K people. The company is managed by 15 executives with a total tenure of roughly 88667 years, averaging almost 5911.0 years of service per executive, having 2533.33 employees per reported executive.

Viatris' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-03-13Anthony MauroDisposed 250000 @ 12.09View
2024-03-05Paul CampbellDisposed 24353 @ 12.33View
2024-02-23Andrew CuneoDisposed 4000 @ 13.5View
2024-02-15Andrew CuneoDisposed 4000 @ 12.5View
2024-01-04Andrew CuneoDisposed 4000 @ 11.5View
2023-12-14Andrew CuneoDisposed 4000 @ 10.5View
2023-11-24Xiangyang (Sean) NiDisposed 14937 @ 9.37View
Monitoring Viatris' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viatris. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Viatris Stock please use our How to Invest in Viatris guide.

Viatris' latest congressional trading

Congressional trading in companies like Viatris, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Viatris by those in governmental positions are based on the same information available to the general public.
2023-04-10Representative Daniel GoldmanAcquired Under $15KVerify
2022-08-01Senator Tommy TubervilleAcquired Under $15KVerify
2022-02-24Representative Earl BlumenauerAcquired Under $15KVerify
2021-06-18Representative Debbie DingellDisposed Under $15KVerify
2021-05-20Representative Scott FranklinDisposed $100K to $250KVerify
2021-04-30Representative Kathy ManningAcquired Under $15KVerify
2021-02-16Representative Peter MeijerDisposed Under $15KVerify
2020-12-30Senator Thomas R. CarperAcquired Under $15KVerify
2020-12-14Representative Josh GottheimerAcquired Under $15KVerify
2020-12-01Representative Mo BrooksDisposed Under $15KVerify
2020-11-17Representative Gilbert CisnerosAcquired Under $15KVerify

Viatris Management Team Effectiveness

The company has return on total asset (ROA) of 0.0279 % which means that it generated a profit of $0.0279 on every $100 spent on assets. This is way below average. Viatris' management efficiency ratios could be used to measure how well Viatris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Viatris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 37.2 B in 2024, whereas Net Tangible Assets are likely to drop (11.3 B) in 2024.
Common Stock Shares Outstanding is likely to gain to about 1.3 B in 2024. Net Income Applicable To Common Shares is likely to gain to about 2 B in 2024

Viatris Workforce Comparison

Viatris is rated first in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 38,461. Viatris totals roughly 38,000 in number of employees claiming about 99% of equities under Health Care industry.

Viatris Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viatris insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viatris' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Viatris insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.7545
83
110
 2,959,274 
 2,476,710 
2023-12-01
0.5
2
4
 33,179 
 52,116 
2023-03-01
0.7456
85
114
 2,780,961 
 2,153,940 
2022-12-01
1.0
2
2
 31,644 
 14,628 
2022-03-01
1.1023
97
88
 2,395,253 
 1,211,415 
2021-06-01
16.5
33
2
 263,107 
 373,950 
2021-03-01
0.6627
55
83
 1,597,276 
 903,027 
2020-12-01
116.0
116
1
 695,916,116 
 689,874,047 

Viatris Notable Stakeholders

A Viatris stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Viatris often face trade-offs trying to please all of them. Viatris' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Viatris' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Viatris Management Performance

The success or failure of an entity such as Viatris often depends on how effective the management is. Viatris management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Viatris management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Viatris management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0  0 
Return On Capital Employed 0.05  0.05 
Return On Assets 0  0 
Return On Equity 0  0 
The data published in Viatris' official financial statements usually reflect Viatris' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Viatris. For example, before you start analyzing numbers published by Viatris accountants, it's critical to develop an understanding of what Viatris' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Viatris' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Viatris' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Viatris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Viatris. Please utilize our Beneish M Score to check the likelihood of Viatris' management manipulating its earnings.

Viatris Workforce Analysis

Traditionally, organizations such as Viatris use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Viatris within its industry.

Viatris Manpower Efficiency

Return on Viatris Manpower

Revenue Per Employee404.8K
Revenue Per Executive1B
Net Income Per Employee1.4K
Net Income Per Executive3.6M
Working Capital Per Employee136.8K
Working Capital Per Executive346.6M
When determining whether Viatris is a strong investment it is important to analyze Viatris' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viatris' future performance. For an informed investment choice regarding Viatris Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viatris. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Viatris Stock please use our How to Invest in Viatris guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Viatris Stock analysis

When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Viatris' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viatris. If investors know Viatris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viatris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
0.48
Earnings Share
0.05
Revenue Per Share
12.853
Quarterly Revenue Growth
(0.01)
The market value of Viatris is measured differently than its book value, which is the value of Viatris that is recorded on the company's balance sheet. Investors also form their own opinion of Viatris' value that differs from its market value or its book value, called intrinsic value, which is Viatris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viatris' market value can be influenced by many factors that don't directly affect Viatris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viatris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viatris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viatris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.